activation is unlikely to occur in poor metabolizers, thereby calling for a selection of other drugs. On the contrary, CYP2C19∗17 (C>T conversion at a promoter region of −806) variant causes increased CYP2C19 activity, which leads to rapid and ultrarapid metabolism ofproton pumpinhibitors ...
Objective To compare the clinical effects of pantoprazole and omeprazole on the antiplatelet therapy of clopidogrel combined with aspirin in patients of acute cerebral infarction lived in Xuzhou China; and to investigate the effects of pantoprazole on the antiplatelet therapy of clopidogrel in patients of...